Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures
For patients with Hashimoto's disease who also have type 2 diabetes, medications like Ozempic may be considered as part of a treatment plan following NICE guidance (NG28)
What You'll Discover: What retatrutide is and how it works in the body
Glutathione S -transferase M1 T1 and P1 polymorphisms and thyroid cancer risk: a meta-analysis
In adipose tissue, GIPR promotes lipid storage and reduces lipolysis, contributing to energy balance
Currently, the reported succinyltransferases and desuccinylases remain limited